专利号:US-8431712-B2 优先权日:2004-02-09 标 题 :Methods for the synthesis of pyridoxamine 发明人:KHALIFAH RAJA G; KEILITZ ROLAND; KOELLNER CHRISTOPH; DEGENHARDT THORSTEN; BRAND STEPHEN ROBERT 权利人:KHALIFAH RAJA G; KEILITZ ROLAND; KOELLNER CHRISTOPH; DEGENHARDT THORSTEN; BRAND STEPHEN ROBERT; NEPHROGENEX INC 摘要:The invention provides non-oxidative methods for the large scale manufacture of pyridoxamine (I) (4-aminomethyl-3-hydroxy-5-hydroxymethyl-2-methylpyridine): n nand salts thereof.n nThe invention also provides intermediate compounds for the synthesis of pyridoxamine, as well as compositions and methods for the treatment and/or prevention of conditions associated with the formation of post-Amadori advanced glycation end-products.
专利号:WO-7800001-A1 优先权日:1977-08-25 标 题:Low temperature synthesis of vitreous bodies and their intermediates 发明人:SAMANTA M 权利人:SAMANTA M 摘要:A method of making glass of high purity and in virtually unlimited shapes via solution deposition on a porous self-supporting body by reaction between a first solution and a second solution; an a product made thereby. The rust solution containing at least one basic glass forming solute is confined within a porous container, the walls of which are substantially impermeable to the basic solute. The second solution containing at least one acidic solute is diffused into the porous container through its walls which are substantially permeable to the said acidic solute. The reaction between the rust solution and the second solution takes place within the porous container leading to the deposition of a self-supporting porous body on the inside walls of the container. The porous body which is crystalline, vitreous or intermediate between the two, is purified by leaching and/or washing, dried and thermally consolidated, to a transparent non-porous glass.
专利号:US-2003176368-A1 优先权日:2001-09-06 标题:Synthesis of epothilones, intermediates thereto and analogues thereof 发明人:DANISHEFSKY SAMUEL J; BISWAS KAUSTAV; CHAPPELL MARK; LIN HONG; NJARDARSON JON T; LEE CHUL BOM; RIVKIN ALEXY; CHOU TING-CHAO 摘要:The present invention provides compounds of formula (I): n n n as described generally and in classes and subclasses herein. The present invention additionally provides pharmaceutical compositions comprising compounds of formula (I) and provides methods of treating cancer comprising administering a compound of formula (I).
专利号:EP-1058679-B1 优先权日:1998-02-25 标 题 :Synthesis of epothilones, intermediates thereto and analogues therof 发明人:DANISHEFSKY SAMUEL J; BALOG AARON; BERTINATO PETER; SU DAI-SHI; CHOU TING-CHAU; MENG DONGFANG; KAMENECKA TED; SORENSEN ERIK J; KUDUK SCOTT; HARRIS CHRISTINA; ZHANG XIU-GUO; BERTINO JOSEPH R 权利人:SLOAN KETTERING INST CANCER 摘要:The present invention provides convergent processes for preparing epothilone A and B, desoxyepothilones A and B, and analogues thereof, useful in the treatment of cancer and cancer which has developed a multidrug-resistant phenotype. Also provided are intermediates useful for preparing said epothilones.
专利号:US-6965034-B2 优先权日:1996-12-03 标题:Synthesis of epothilones, intermediates thereto and analogues thereof 发明人:DANISHEFSKY SAMUEL J; BERTINATO PETER; SU DAI-SHI; MENG DONGFANG; CHOU TING-CHAO; KAMENECKA TED; SORENSEN ERIK J; BALOG AARON; SAVIN KENNETH A; KUDUK SCOTT; HARRIS CHRISTINA; ZHANG XIU-GUO; BERTINO JOSEPH R 权利人:SLOAN KETTERING INST CANCER 摘要:The present invention provides convergent processes for preparing epothilone A and B, desoxyepothilones A and B, and analogues thereof, useful in the treatment of cancer and cancer which has developed a multidrug-resistant phenotype. Also provided are intermediates useful for preparing said epothilones.
专利号:US-2012282255-A1 优先权日:2011-04-07 标题 :Methods and compositions for the treatment of alcoholism and alcohol dependence 发明人:PLUCINSKI GREG 权利人:PLUCINSKI GREG 摘要:The present invention provides for compositions and methods for treating or preventing addictive and compulsive diseases and disorders, particular alcohol-related diseases and disorders, disclosed herein. The GLP activators of the present invention are effective against various alcohol and drug dependency diseases. In accordance with the invention, the present compositions and methods can be used to intercede upstream or downstream in the signal transduction cascade involved in GLP action to treat various alcohol and drug dependency diseases. In one embodiment, the synthesis or release of endogenous GLP can be stimulated. In another embodiment, the endogenous synthesis or release of another molecule active in the cascade downstream from GLP, (e.g., a molecule produced in response to GLP binding to a receptor), can be stimulated. Accordingly, the methods and compositions of the invention are useful for preventing, treating, diagnosing, or monitoring the progression various alcohol and drug dependency diseases disclosed herein.
1: Silva EP, Wiltbank MC, Machado AB, Gambin LS, Dias MM, Chaiben MFC, Bernardi ML, Borges JBS. Optimizing timed AI protocols for Angus beef heifers: Comparison of induction of synchronized ovulation with estradiol cypionate or GnRH. Theriogenology. 2018 Jul 27;121:7-12. doi: 10.1016/j.theriogenology.2018.07.019. [Epub ahead of print] doi: 10.1016/j.theriogenology.2018.06.030. Epub 2018 Jul 4. Available from http://www.ncbi.nlm.nih.gov/books/NBK501761/ doi: 10.1016/j.theriogenology.2017.11.022. Epub 2018 Apr 4. doi: 10.1016/j.theriogenology.2018.03.020. Epub 2018 Mar 21. doi: 10.1097/FBP.0000000000000391. doi: 10.1016/j.rvsc.2018.01.010. Epub 2018 Jan 31. doi: 10.1016/j.theriogenology.2018.01.017. Epub 2018 Jan 31. doi: 10.1016/j.theriogenology.2018.01.011. Epub 2018 Jan 31. doi: 10.3168/jds.2017-13570. Epub 2018 Feb 7. doi: 10.1093/jas/skx043. doi: 10.1186/s40104-017-0211-3. eCollection 2017. 13: Martins T, Talamoni JP, Sponchiado M, Maio JRG, Nogueira GP, Pugliesi G, Binelli M. Impact of estradiol cypionate prior to TAI and progesterone supplementation at initial diestrus on ovarian and fertility responses in beef cows. Theriogenology. 2017 Dec;104:156-163. doi: 10.1016/j.theriogenology.2017.08.017. Epub 2017 Aug 19. doi: 10.1016/j.theriogenology.2017.03.010. Epub 2017 Mar 29. doi: 10.1515/ap-2017-0076. doi: 10.1016/j.anireprosci.2017.03.025. Epub 2017 Apr 4. doi: 10.3168/jds.2016-11519. Epub 2016 Nov 23. doi: 10.1016/j.theriogenology.2016.07.015. Epub 2016 Jul 25. doi: 10.3168/jds.2016-11220. Epub 2016 Aug 24. doi: 10.1016/j.theriogenology.2016.06.012. Epub 2016 Jun 23.
合成参考文献
摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198 摘要:S72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664